INITIAL FILING

Company

AYTU BIOPHARMA, INC

Filed

May 12, 2017

Accession Number

0001706226-17-000002

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →